EUROPEAN JOURNAL OF
PHARMACEUTICAL AND MEDICAL RESEARCH

( An ISO 9001:2015 Certified International Journal )

An International Peer Reviewed Journal for Pharmaceutical, Medical & Biological Sciences

An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)

European Journal of Pharmaceutical and Medical Research (EJPMR) has indexed with various reputed international bodies like : Google Scholar , Indian Science Publications , InfoBase Index (In Process) , SOCOLAR, China , Research Bible, Fuchu, Tokyo. JAPAN , International Society for Research activity (ISRA) , Scientific Indexing Services (SIS) , Polish Scholarly Bibliography , Global Impact Factor (GIF) (Under Process) , Universal Impact Factor , International Scientific Indexing (ISI), UAE  , Index Copernicus , CAS (A Division of American Chemical Society) USA (Under Process) , Directory of Open Access Journal (DOAJ, Sweden, in process) , UDLedge Science Citation Index , CiteFactor , Directory Of Research Journal Indexing (DRJI) , Indian citation Index (ICI) , Journal Index (JI, Under Process) , Directory of abstract indexing for Journals (DAIJ) , Open Access Journals (Under Process) , Impact Factor Services For International Journals (IFSIJ) , Cosmos Impact Factor , Jour Informatics (Under Process) , Eurasian Scientific Journal Index (ESJI) , International Innovative Journal Impact Factor (IIJIF) , Science Library Index, Dubai, United Arab Emirates , Pubmed Database [NLM ID: 101669306] (Under Process) , IP Indexing (IP Value 2.40) , Web of Science Group (Under Process) , Directory of Research Journals Indexing , Scholar Article Journal Index (SAJI) , International Scientific Indexing ( ISI ) , 

 ISSN 2394-3211

Impact Factor: 6.222

 ICV - 79.57

Abstract

PROFILE OF INTERISTIAL LUNG DISEASES AT TERTIARY CARE CENTRE OF NORTHERN INDIA

Kumar Adesh (MD), *Yadav Prashant (MD), Gupta K. Ashish (MD), Gautam K. Aditya (MD), Kumar Anand (MD) and Chaudhri Sudhir (MD) 

ABSTRACT

Background: Interstitial lung disease (ILD) is a heterogeneous group of lung diseases which are challenging to the clinicians. There is limited data on the presentation and diagnosis of these patients from India. The present study was planned to analyse the spectrum of ILD encountered at a tertiary referral centre in India to determine the clinical profile of the disease. Material and Methods: This study includes 116 patients diagnosed to have ILDs during the years 20013–2015 at tertiary care centre of north India. The diagnosis of ILD was based on clinical, radiological parameters, laboratory parameters, spirometric parameters and histopathology wherever available. Classification of ILD was done as per The American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of Idiopathic Interstitial Pneumonias 2001 guidelines were used in the diagnosis. Result: The overall mean age at presentation was 45.24 years, 54.83 years in IPF, 44.60 years in HSP, 43.60 years in NSIP and 41.56 years in Sarcoidosis. Of the 116 ILD cases there were 70 male (60.34%) and 46 (39.66%) females. The overall mean duration of symptoms at diagnosis was 2.47 years, 1.5 years in IPF, 1.2 years in HSP, 1.5 years in NSIP and 3 years in Sarcoidosis. The most frequent presenting symptom in the ILD was cough present in 98 (84.45%), followed by exertional dyspnoea in 86 (74.13%). Conclusion: Interistial pulmonary fibrosis is the most common and Hypersensitivity Pneumonitis is the second common Interistial Lung Disease in our study. Being progressive disease most of the patients presented to us in advance stage of disease and in most of the cases anti tubercular treatment was started by the treating physician without being extensive evaluation because of lack of awareness among physicians.

Keywords: Interistial Lung Disease, Idiopathic Pulmonary Fibrosis, Diffuse Parechymal Lung Disease.


[Full Text Article]

INDEXING

NEWS & UPDATION

  • New Issue Published

    Its Our pleasure to inform you that, EJPMR 1 November 2021 Issue has been Published, Kindly check it on http://www.ejpmr.com/home/current_issues

  • EJPMR: NOVEMBER ISSUE PUBLISHED

    NOVEMBER Issue has been successfully launched on 1 November 2021.

  • EJPMR New Impact Factor

    Its our Pleasure to Inform you that EJPMR Impact Factor has been increased from  5.804 to 6.222, due to high quality Publication at International Level

  • Index Copernicus Value

    EJPMR Received Index Copernicus Value 79.57, due to High Quality Publication in EJPMR at International Level

  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.

    .

  • Article Invited for Publication

    Article are invited for publication in EJPMR Coming Issue

Google Scholar Indian Science Publications InfoBase Index (In Process) SOCOLAR, China Research Bible, Fuchu, Tokyo. JAPAN International Society for Research activity (ISRA) Scientific Indexing Services (SIS) Polish Scholarly Bibliography Global Impact Factor (GIF) (Under Process) Universal Impact Factor International Scientific Indexing (ISI), UAE Index Copernicus CAS (A Division of American Chemical Society) USA (Under Process) Directory of Open Access Journal (DOAJ, Sweden, in process) UDLedge Science Citation Index CiteFactor Directory Of Research Journal Indexing (DRJI) Indian citation Index (ICI) Journal Index (JI, Under Process) Directory of abstract indexing for Journals (DAIJ) Open Access Journals (Under Process) Impact Factor Services For International Journals (IFSIJ) Cosmos Impact Factor Jour Informatics (Under Process) Eurasian Scientific Journal Index (ESJI) International Innovative Journal Impact Factor (IIJIF) Science Library Index, Dubai, United Arab Emirates Pubmed Database [NLM ID: 101669306] (Under Process) IP Indexing (IP Value 2.40) Web of Science Group (Under Process) Directory of Research Journals Indexing Scholar Article Journal Index (SAJI) International Scientific Indexing ( ISI )